Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Cognizant, a global provider of business process outsourcing services, has entered a multi-year agreement with AstraZeneca to deliver comprehensive biostatistics and medical reporting services to generate clinical study reports.
Subscribe to our email newsletter
Under the terms of the deal, Cognizant will offer centralized statistical programming, statistical analysis, medical writing, and document publishing services, covering clinical data reporting, from case report forms to clinical study reports.
Cognizant will leverage its Web 2.0-based platform, Cognizant 2.0, to support knowledge sharing and collaboration there by helping in the management of clinical studies across different countries besides delivering productivity benefits to AstraZeneca.
AstraZeneca will benefit by increasing its operational efficiency, reducing cycle times, and optimizing costs.
The pharmaceutical giant will continue to own and manage major scientific and medical activities associated with the design of clinical trial programs, and the interpretation of data from Cognizant.